CD47 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.248340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.808030E-02
Normal-vs-Stage2
1.391920E-02
Normal-vs-Stage3
1.057910E-02
Normal-vs-Stage4
4.997200E-01
Stage1-vs-Stage2
8.167400E-01
Stage1-vs-Stage3
1.358800E-01
Stage1-vs-Stage4
2.588800E-01
Stage2-vs-Stage3
8.718200E-02
Stage2-vs-Stage4
1.479030E-01
Stage3-vs-Stage4
1.048850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.158400E-02
Normal-vs-AfricanAmerican
5.302100E-02
Normal-vs-Asian
2.425500E-02
Caucasian-vs-AfricanAmerican
7.183400E-01
Caucasian-vs-Asian
9.695600E-01
AfricanAmerican-vs-Asian
7.271400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.578400E-03
Normal-vs-Female
2.236100E-02
Male-vs-Female
3.153000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.602220E-02
Normal-vs-Age(41-60Yrs)
6.966000E-02
Normal-vs-Age(61-80Yrs)
6.978500E-03
Normal-vs-Age(81-100Yrs)
8.649000E-04
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.713790E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.874400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.995200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.041100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.222200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.082200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.777200E-03
Normal-vs-Daily Drinker
1.572010E-02
Normal-vs-Weekly Drinker
2.436400E-03
Normal-vs-Occasional Drinker
1.067220E-01
Normal-vs-Social Drinker
5.673600E-02
Non Drinker-vs-Daily Drinker
8.230800E-01
Non Drinker-vs-Weekly Drinker
6.520800E-01
Non Drinker-vs-Occasional Drinker
3.511200E-01
Non Drinker-vs-Social Drinker
4.978200E-01
Daily Drinker-vs-Weekly Drinker
8.342600E-01
Daily Drinker-vs-Occasional Drinker
5.058200E-01
Daily Drinker-vs-Social Drinker
6.622800E-01
Weekly Drinker-vs-Occasional Drinker
6.108000E-01
Weekly Drinker-vs-Social Drinker
7.880000E-01
Occasional Drinker-vs-Social Drinker
8.371600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.106200E-01
Normal-vs-Grade 2
4.313500E-02
Normal-vs-Grade 3
5.499800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.994300E-02
Grade 1-vs-Grade 3
6.351600E-02
Grade 1-vs-Grade 4
3.106200E-01
Grade 2-vs-Grade 3
9.798200E-01
Grade 2-vs-Grade 4
4.313500E-02
Grade 3-vs-Grade 4
5.499800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.164400E-03
Normal-vs-NonDiabetic
1.167760E-02
Diabetic-vs-NonDiabetic
1.854640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.886440E-02
Normal-vs-NoPancreatitis
9.199200E-03
Pancreatitis-vs-NoPancreatitis
8.330600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.250030E-02
Normal-vs-N1
1.522350E-02
N0-vs-N1
5.916600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.354400E-01
Normal-vs-TP53-NonMutant
1.388090E-02
TP53-Mutant-vs-TP53-NonMutant
1.233930E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
